Application 201280
- Type
- NDA
- Sponsor
- BOEHRINGER INGELHEIM
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TRADJENTA | LINAGLIPTIN | TABLET;ORAL | 5MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0597-0140 | Tradjenta | linagliptin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0140 | Tradjenta | linagliptin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0140 | Tradjenta | linagliptin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0140 | Tradjenta | linagliptin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0140 | Tradjenta | linagliptin | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 50090-4383 | Tradjenta | linagliptin | A-S Medication Solutions | NDA | Current |
| 50090-4383 | Tradjenta | linagliptin | A-S Medication Solutions | NDA | Current |
| 55154-0410 | Tradjenta | linagliptin | Cardinal Health 107, LLC | NDA | Current |
| 55154-0410 | Tradjenta | linagliptin | Cardinal Health | NDA | Current |
| 55154-0410 | Tradjenta | linagliptin | Cardinal Health | NDA | Current |
| 55154-0410 | Tradjenta | linagliptin | Cardinal Health | NDA | Current |
| 55154-0410 | Tradjenta | linagliptin | Cardinal Health | NDA | Current |